114 related articles for article (PubMed ID: 34230124)
21. Experimental therapy for neurofibromatosis I shows promise: cancer drug shrinks some plexiform neuromas.
Am J Med Genet A; 2013 Feb; 161A(2):viii-ix. PubMed ID: 23348988
[No Abstract] [Full Text] [Related]
22. Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening.
Kraniak JM; Chalasani A; Wallace MR; Mattingly RR
Exp Neurol; 2018 Jan; 299(Pt B):289-298. PubMed ID: 29055717
[TBL] [Abstract][Full Text] [Related]
23. Plexiform neurofibromas in NF1: toward biologic-based therapy.
Packer RJ; Gutmann DH; Rubenstein A; Viskochil D; Zimmerman RA; Vezina G; Small J; Korf B
Neurology; 2002 May; 58(10):1461-70. PubMed ID: 12041525
[TBL] [Abstract][Full Text] [Related]
24. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors.
Wallace MR; Rasmussen SA; Lim IT; Gray BA; Zori RT; Muir D
Genes Chromosomes Cancer; 2000 Feb; 27(2):117-23. PubMed ID: 10612798
[TBL] [Abstract][Full Text] [Related]
25. Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma.
Kluwe L; Friedrich R; Mautner VF
Genes Chromosomes Cancer; 1999 Mar; 24(3):283-5. PubMed ID: 10451710
[TBL] [Abstract][Full Text] [Related]
26. Off‑target effect of imatinib and nilotinib on human vitamin D3 metabolism.
Kroschwald L; Suttorp M; Tauer JT; Zimmermann N; Günther C; Bauer A
Mol Med Rep; 2018 Jan; 17(1):1382-1388. PubMed ID: 29115640
[TBL] [Abstract][Full Text] [Related]
27. Regulation of cell growth, c-myc mRNA, and 1,25-(OH)2 vitamin D3 receptor in C3H/10T1/2 mouse embryo fibroblasts by calcipotriol and 1,25-(OH)2 vitamin D3.
Trydal T; Lillehaug JR; Aksnes L; Aarskog D
Acta Endocrinol (Copenh); 1992 Jan; 126(1):75-9. PubMed ID: 1310564
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK.
Na Y; Hall A; Choi K; Hu L; Rose J; Coover RA; Miller A; Hennigan RF; Dombi E; Kim MO; Subramanian S; Ratner N; Wu J
Oncogene; 2021 Feb; 40(5):951-963. PubMed ID: 33293695
[TBL] [Abstract][Full Text] [Related]
29. B-scan ultrasonographic monitoring of orthotopic xenografted plexiform neurofibroma in mice.
Gleiss J; Demestre M; Spyra M; Eschenhagen T; Hagel C; Mautner VF; Kluwe L; Friedrich RE
In Vivo; 2013; 27(6):723-7. PubMed ID: 24292574
[TBL] [Abstract][Full Text] [Related]
30. Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells.
Fishbein L; Eady B; Sanek N; Muir D; Wallace MR
Cancer Genet Cytogenet; 2005 Mar; 157(2):181-6. PubMed ID: 15721644
[TBL] [Abstract][Full Text] [Related]
31. Imatinib and nilotinib inhibit hematopoietic progenitor cell growth, but do not prevent adhesion, migration and engraftment of human cord blood CD34+ cells.
Belle L; Bruck F; Foguenne J; Gothot A; Beguin Y; Baron F; Briquet A
PLoS One; 2012; 7(12):e52564. PubMed ID: 23285088
[TBL] [Abstract][Full Text] [Related]
32. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
33. Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis.
Akashi N; Matsumoto I; Tanaka Y; Inoue A; Yamamoto K; Umeda N; Tanaka Y; Hayashi T; Goto D; Ito S; Sekiguchi K; Sumida T
Mod Rheumatol; 2011 Jun; 21(3):267-75. PubMed ID: 21188449
[TBL] [Abstract][Full Text] [Related]
34. Effects of PKC412, nilotinib, and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity.
Weisberg E; Wright RD; Jiang J; Ray A; Moreno D; Manley PW; Fabbro D; Hall-Meyers E; Catley L; Podar K; Kung AL; Griffin JD
Gastroenterology; 2006 Dec; 131(6):1734-42. PubMed ID: 17087936
[TBL] [Abstract][Full Text] [Related]
35. Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.
Le LQ; Liu C; Shipman T; Chen Z; Suter U; Parada LF
Cancer Res; 2011 Jul; 71(13):4686-95. PubMed ID: 21551250
[TBL] [Abstract][Full Text] [Related]
36. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
Kinoshita K; Nakagawa K; Hamada J; Hida Y; Tada M; Kondo S; Moriuchi T
Int J Oncol; 2010 Oct; 37(4):869-77. PubMed ID: 20811709
[TBL] [Abstract][Full Text] [Related]
37. Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice.
Rhee CK; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim YK; Kim KH; Kim TJ; Kim JW
Respiration; 2011; 82(3):273-87. PubMed ID: 21659722
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D Prevents Pancreatic Cancer-Induced Apoptosis Signaling of Inflammatory Cells.
Moz S; Contran N; Facco M; Trimarco V; Plebani M; Basso D
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32679840
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph
Willmann M; Sadovnik I; Eisenwort G; Entner M; Bernthaler T; Stefanzl G; Hadzijusufovic E; Berger D; Herrmann H; Hoermann G; Valent P; Rülicke T
Exp Hematol; 2018 Jan; 57():50-59.e6. PubMed ID: 29031704
[TBL] [Abstract][Full Text] [Related]
40. Impact of ABCB1 1236C > T-2677G > T-3435C > T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinib.
Dessilly G; Panin N; Elens L; Haufroid V; Demoulin JB
Sci Rep; 2016 Jul; 6():29559. PubMed ID: 27405085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
